Herbert Kogler
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Herbert Kogler.
Chemistry: A European Journal | 2012
Cosima Dufour; Joachim Wink; Michael Kurz; Herbert Kogler; Helene Olivan; Serge Sablé; Winfried Heyse; Martin Gerlitz; Luigi Toti; Antje Nußer; Astrid Rey; Cédric Couturier; Armin Bauer; Mark Brönstrup
In an antibiotic lead discovery program, the known strain Streptomyces armeniacus DSM19369 has been found to produce three new natural products when cultivated on a malt-containing medium. The challenging structural elucidation of the isolated compounds was achieved by using three independent methods, that is, chemical degradation followed by NMR spectroscopy, a computer-assisted structure prediction algorithm, and X-ray crystallography. The compounds, named armeniaspirol A-C (2-4), exhibit a compact, hitherto unprecedented chlorinated spiro[4.4]non-8-ene scaffold. Labeling experiments with [1-(13)C] acetate, [1,2-(13)C2] acetate, and [U-(13)C] proline suggest a biosynthesis through a rare two-chain mechanism. Armeniaspirols displayed moderate to high in vitro activities against gram-positive pathogens such as methicillin-resistant S. aureus (MRSA) or vancomycin resistant E. faecium (VRE). As analogue 2 was active in vivo in an MRSA sepsis model, and showed no development of resistance in a serial passaging experiment, it represents a new antibiotic lead structure.
Tetrahedron Letters | 1984
Horst Kessler; Günther Becker; Herbert Kogler; Michael Wolff
Abstract 2-(2-pyridyl-)ethyl esters are used as chemically inert, highly selective protecting groups that are removable under mild conditions via a two step procedure.
Tetrahedron Letters | 1991
Sugata Chatterjee; Erra K. S. Vijayakumar; Christopher M. M. Franco; Urmila P. Borde; Jurgen Blumbach; B. N. Ganguli; Hans-Wolfram Fehlhaber; Herbert Kogler
Butalactin, (2R*,3S*)-2-(4′,5′-epoxy-hex-2′E-en)oyl-2-hydroxy-3-hydroxymethylbutanolide,(1) is a new antibiotic produced by a Streptomyces sp. HIL Y-86,36923. Butalactin is structurally related to the butyrolactones produced as signal molecules by microorganisms.
Tetrahedron | 1998
Triptikumar Mukhopadhyay; Suresh Rudra Nadkarni; M.V. Patel; R. G. Bhat; Kalyanapuram Rajagopalan Desikan; B. N. Ganguli; Richard Helmut Rupp; H.-W. Fehlhaber; Herbert Kogler
Abstract A new antifungal macrocyclic lactone maclafungin, belonging to the oligomycin class has been isolated from an actinomycete sp. Y-8521050. The antibiotic, having a molecular formula of C46H80O12, is active against several fungal species. Its structure was elucidated by analysis of 2D NMR experiments.
The Journal of Antibiotics | 1992
Sukumar Chatterjee; Sugata Chatterjee; Shashikant J. Lad; Mahesh S. Phansalkar; Richard Helmut Rupp; B. N. Ganguli; Hans-Wolfram Fehlhaber; Herbert Kogler
The Journal of Antibiotics | 2000
Laszlo Vertesy; Eberhard Ehlers; Herbert Kogler; Michael Kurz; Johannes Meiwes; Gerhard Seibert; Martin Vogel; Peter Hammann
Helvetica Chimica Acta | 1995
Laszlo Vertesy; Werner Aretz; Hans-Wolfram Fehlhaber; Herbert Kogler
Journal of Organic Chemistry | 1994
Sugata Chatterjee; Erra K. S. Vijayakumar; Suresh Rudra Nadkarni; M. V. Patel; Jurgen Blumbach; Bimal Naresh Ganguli; H.-W. Fehlhaber; Herbert Kogler; Lsszlo Dr Vertesy
The Journal of Antibiotics | 1992
Triptikumar Mukhopadhyay; Kirity Roy; R. G. Bhat; S. N. Sawant; J. Blumbach; B. N. Ganguli; H.-W. Fehlhaber; Herbert Kogler
The Journal of Antibiotics | 1987
Triptikumar Mukhopadhyay; B. N. Ganguli; H.-W. Fehlhaber; Herbert Kogler; L. Vertesy